
ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Check out this recent study in Alimentary Pharmacology and Therapeutics showing that aspirin’s decreased risk of colorectal cancer (CRC) may potentially occur by modulating the gut microbiome. AP&T: Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial […]